Testing a new PET scan for liver cancer before RFA
Part of Cancer, Digestive system clinical trials.
This study tests a new PET scan (Ga-68 Dolacga) to see how well it images liver cancer before you have a standard heat treatment (radiofrequency ablation). The scan may help doctors plan your procedure more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a liver cancer diagnosis (HCC)
- Your cancer is very early or early stage (BCLC 0 or A): either a single tumor ≤2 cm, or up to three tumors all ≤3 cm, or one tumor up to 5 cm
- You are able to be fully active (ECOG 0)
- You are 18 years or older
- You have not had local treatment for the specific tumor being studied (such as surgery, ethanol injection, or transplant)
- There is no spread into blood vessels or outside the liver
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new type of imaging scan (called 68Ga-NYM207 PET/CT) that may help doctors better find and understand liver cancer. You would receive the scan once to see if it helps doctors plan your treatment or monitor your cancer.
This trial uses a special PET scan (68Ga-FAPI) to see how well systemic therapy is working in people with advanced liver cancer that can't be removed by surgery. The goal is to find a better way to measure treatment effectiveness.
This trial tests a special PET scan (18F-FSPG) to help guide therapy for people with liver cancer (HCC) who are planning to receive Y90 radioembolization. The scan may help doctors better plan your treatment.
This study looks at liver metastases treated with a procedure that destroys tumors (ablation) and then checks tumor tissue right away. The team wants to see whether the tissue results can guide immediate retreatment to better control cancer in the liver.
This trial uses a special PET scan that targets a protein found in liver cancer cells. It aims to see if this new scan works better than an enhanced MRI to find liver cancer. If you have suspected or confirmed liver cancer, this study might help guide your care.
This trial studies how well a special imaging test (68Ga-FAPI PET/MRI) can detect and evaluate hepatocellular carcinoma (HCC), a type of liver cancer. It may help doctors confirm diagnosis and plan next steps by seeing how the cancer takes up the tracer.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.